EUVIMEDEUVIMED entdecken
Open Access

Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension

Ahmed U Fayyaz, Michael S Sabbah, Surendra Dasari, Leigh G Griffiths, Hilary M DuBrock iD, Ying Wang, M Cristine Charlesworth iD, Barry A Borlaug iD, Sarah M Jenkins, William D Edwards, Margaret M Redfield

Cardiovascular Research · 17.03.2023 · 119 (1) · 268-282

DOI: 10.1093/cvr/cvac005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 12.01.2022. Verfasst von Ahmed U Fayyaz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Pulmonary Veins, Hypertension, Pulmonary, Heart Failure. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Mayo Foundation and the Division of Circulatory Failure Research Program, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In heart failure (HF), pulmonary venous hypertension (PVH) produces pulmonary hypertension (PH) with remodeling of pulmonary veins (PV) and arteries (PA). In a porcine PVH model, we performed proteomic-based bioinformatics to investigate unique pathophysiologic mechanisms mediating PA and PV remodeling. Methods and results Large PV were banded (PVH, n = 10) or not (Sham, n = 9) in piglets. At sacrifice, PV and PA were perfusion labelled for vessel-specific histology and proteomics. The PA and PV were separately sampled with laser-capture micro-dissection for mass spectrometry. Pulmonary vascular resistance [Wood Units; 8.6 (95% confidence interval: 6.3, 12.3) vs. 2.0 (1.7, 2.3)] and PA [19.9 (standard error of mean, 1.1) vs. 10.3 (1.1)] and PV [14.2 (1.2) vs. 7.6 (1.1)] wall thickness/external diameter (%) were increased in PVH (P < 0.05 for all). Similar numbers of proteins were identified in PA (2093) and PV (2085) with 94% overlap, but biological processes differed. There were more differentially expressed proteins (287 vs. 161), altered canonical pathways (17 vs. 3), and predicted upstream regulators (PUSR; 22 vs. 6) in PV than PA. In PA and PV, bioinformatics indicated activation of the integrated stress response and mammalian target of rapamycin signalling with dysregulated growth. In PV, there was also activation of Rho/Rho-kinase signalling with decreased actin cytoskeletal signalling and altered tight and adherens junctions, ephrin B, and caveolae-mediated endocytosis signalling; all indicating disrupted endothelial barrier function. Indeed, protein biomarkers and the top PUSR in PV (transforming growth factor-beta) suggested endothelial to mesenchymal transition in PV. Findings were similar in human autopsy specimens.

Conclusion

These findings provide new therapeutic targets to oppose pulmonary vascular remodeling in HF-related PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary VeinsHypertension, PulmonaryHeart FailureAnimalsHumansSwineProteomicsPulmonary ArteryLungMammals

Stichwörter der Autor:innen

HFpEFHaemodynamicHeart failureHistomorphometryLaser-capture micro-dissectionMass spectrometryProteomicsPulmonary hypertensionPulmonary vein

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
  • Molecular Genome Facility Proteomics Core, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

ORCID-Profile: Hilary M DuBrock, M Cristine Charlesworth, Barry A Borlaug

Förderung

  • NHLBI NIH HHS
  • Mayo Foundation and the Division of Circulatory Failure Research Program
  • National Institute of Health

Zitieren

APA

Fayyaz, A. U., Sabbah, M. S., Dasari, S., Griffiths, L. G., DuBrock, H. M., Wang, Y., Charlesworth, M. C., Borlaug, B. A., Jenkins, S. M., Edwards, W. D., & Redfield, M. M. (2023). Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension. Cardiovascular Research, 119(1), 268-282. https://doi.org/10.1093/cvr/cvac005

Vancouver

Fayyaz AU, Sabbah MS, Dasari S, Griffiths LG, DuBrock HM, Wang Y, et al. Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension. Cardiovascular Research. 2023;119(1):268-282. doi:10.1093/cvr/cvac005

BibTeX
@article{Fayyaz2023,
  author = {Fayyaz, Ahmed U and Sabbah, Michael S and Dasari, Surendra and Griffiths, Leigh G and DuBrock, Hilary M and Wang, Ying and Charlesworth, M Cristine and Borlaug, Barry A and Jenkins, Sarah M and Edwards, William D and Redfield, Margaret M},
  title = {Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension},
  journal = {Cardiovascular Research},
  year = {2023},
  volume = {119},
  number = {1},
  pages = {268--282},
  doi = {10.1093/cvr/cvac005}
}
Kostenlos starten →